Epsilon M&A Deal Report - OTC-Business of Moberg Pharma (MPJ OTC)
Transaction Multiples for the Valuation of Private Companies
Private Group Led by Signet Healthcare Partners & RoundTable Healthcare Partners / OTC-Business of Moberg Pharma (MPJ OTC)
No EMAT :
100875
Announced Date :
12/02/2019
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Private Group Led by Signet Healthcare Partners & RoundTable Healthcare Partners
Target :
OTC-Business of Moberg Pharma (MPJ OTC)
Country :
Sweden
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
The OTC business of Moberg Pharma (MPJ OTC) mainly comprised the marketing and distribution of the OTC brands Kerasal Nail®, New Skin® and Dermoplast®. > Three large brands, each with a leading...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
|
|
|
|
| Current |
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/11/2019 | Private Group led by Omnes Capital | Biofutur | Val-D'Oise | * | 100831 |
| 21/06/2019 | Karo Pharma | Trimb | Sweden | *** | 100797 |
Source: Epsilon Research / EMAT
